Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) Sees Significant Increase in Short Interest

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) saw a significant increase in short interest during the month of October. As of October 30th, there was short interest totaling 192,457 shares, an increase of 1,629.0% from the October 15th total of 11,131 shares. Based on an average trading volume of 648 shares, the short-interest ratio is currently 297.0 days.

Fisher & Paykel Healthcare Price Performance

Shares of FSPKF opened at $26.99 on Wednesday. Fisher & Paykel Healthcare has a 12-month low of $19.01 and a 12-month high of $28.09. The stock’s fifty day simple moving average is $26.39 and its 200-day simple moving average is $23.79.

Analyst Ratings Changes

Several research firms have recently commented on FSPKF. Citigroup raised shares of Fisher & Paykel Healthcare to a “buy” rating in a research note on Thursday, September 10th. Royal Bank Of Canada upgraded shares of Fisher & Paykel Healthcare from a “sector perform” rating to an “outperform” rating in a research report on Tuesday, September 15th. Two research analysts have rated the stock with a Buy rating. According to MarketBeat.com, Fisher & Paykel Healthcare presently has a consensus rating of “Buy”.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that develops, manufactures and markets products for respiratory care, acute care and home healthcare. Its technologies are designed to help patients breathe more comfortably and effectively across hospital and home settings. The company’s product portfolio includes respiratory humidification systems, nasal high-flow therapy products, continuous positive airway pressure (CPAP) and noninvasive ventilation masks, as well as related circuits, interfaces and consumables.